INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,592 Cr | ₹1,329 Cr | ₹748 Cr | ₹612 Cr | ₹404 Cr |
What is the latest Total Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,592 Cr |
| Mar2024 | ₹1,329 Cr |
| Mar2023 | ₹748 Cr |
| Mar2022 | ₹612 Cr |
| Mar2021 | ₹404 Cr |
How is Total Liabilities of INNOVA CAPTAB Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,592 Cr | 19.72 | |
| Mar2024 | ₹1,329 Cr | 77.68 | |
| Mar2023 | ₹748 Cr | 22.22 | |
| Mar2022 | ₹612 Cr | 51.35 | |
| Mar2021 | ₹404 Cr | - | |
Compare Total Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,988.6 Cr | -3% | -3.9% | -32.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -3% |
-3.9% |
-32.2% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses